Clinical Research Directory
Browse clinical research sites, groups, and studies.
eUltra 10k - Biofreedom Ultra
Sponsor: Biosensors Europe SA
Summary
This registry captures data on BioFreedomTM Ultra CoCr DCS in standard clinical practice (real world population) and serves as Post Market Clinical Follow up (PMCF) as part of the Post-Market Surveillance.
Official title: A Post-Market Registry of the BioFreedom Ultra CoCr Biolimus A9 Coated Coronary Stent System
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
10000
Start Date
2023-06-15
Completion Date
2029-03-30
Last Updated
2026-03-04
Healthy Volunteers
No
Conditions
Interventions
Biofreedom Ultra
The BioFreedomTM Ultra CoCr DCS is a combination product consisting of two key components: the cobalt chromium stent platform coated abluminally with the active ingredient BA9TM (polymer and carrier free) and the delivery system.
Locations (10)
Krankenhaus Barmherzige Brüder
Eisenstadt, Austria
Clinique Des Domes Psr
Clermont-Ferrand, France
Klinikum Lippe
Detmold, Germany
Hospital Marques Valdecilla
Santander, Spain
University and Hospital Fribourg
Fribourg, Switzerland
Universitäres Herzzentrum
Zurich, Switzerland
Military hospital
Tunis, Tunisia
Al Qassimi Hospital
Sharjah city, United Arab Emirates
Royal Bournemouth hospital
Bournemouth, United Kingdom
Golden Jubilee National Hospital
Glasgow, United Kingdom